P-57 Atezolizumab in combination with bevacizumab in patients with unresectable HCC previously untreated with systemic therapy: Interim analysis results from phase IIIb Italian AMETHISTA trial

• DOI: 10.1016/j.annonc.2023.04.113
• Publication Date: 2023-07-01T14:54:35Z
• Authors: E. Martinelli; G. Masi; F. Piscaglia; G. Cabibbo; M. Di Maio; A. Gasbarrini; M. Iavarone; E. Pellegrini; V. Mazzaferro; A. Ballestrero; C. Garufi; F. Bergamo; C. Celsa; D. Marino; F. Tovoli; F. Ponziani; T. Pressiani; C. Astolfi; F. Ciardiello; B. Daniele; L. Rimassa